|
CA1136620A
(en)
|
1979-01-08 |
1982-11-30 |
Ulf P.F. Lindahl |
Heparin fragments having selective anticoagulation activity
|
|
JPS63246396A
(ja)
*
|
1987-03-31 |
1988-10-13 |
Shiseido Co Ltd |
モノクロ−ナル抗体
|
|
FR2614026B1
(fr)
*
|
1987-04-16 |
1992-04-17 |
Sanofi Sa |
Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
|
|
SE9002550D0
(sv)
*
|
1990-08-01 |
1990-08-01 |
Kabivitrum Ab |
Heparinfragment
|
|
SE9003181D0
(sv)
|
1990-10-04 |
1990-10-04 |
Kabivitrum Ab |
Use of heparin fraction
|
|
US5250519A
(en)
|
1991-03-29 |
1993-10-05 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
|
US5280016A
(en)
|
1991-03-29 |
1994-01-18 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
|
JPH0532703A
(ja)
*
|
1991-07-26 |
1993-02-09 |
Terumo Corp |
低分子量ヘパリン誘導体の製造法
|
|
AU5442594A
(en)
*
|
1992-10-13 |
1994-05-09 |
Virginia Commonwealth University |
Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
|
|
US5527785A
(en)
|
1993-05-14 |
1996-06-18 |
The Regents Of The University Of California |
Selectin receptor modulating compositions
|
|
US5744457A
(en)
*
|
1995-03-31 |
1998-04-28 |
Hamilton Civic Hospitals Research Development Inc. |
Compositions and methods for inhibiting thrombogenesis
|
|
ATE224918T1
(de)
*
|
1995-03-31 |
2002-10-15 |
Hamilton Civic Hospitals Res |
Zusammensetzung zur hemmung der thromboseentstehung
|
|
US5993810A
(en)
|
1996-03-15 |
1999-11-30 |
Lebovitz; Shamir Israel |
Method of softening or ripening the cervix of a female mammal using collagenase
|
|
US5767269A
(en)
*
|
1996-10-01 |
1998-06-16 |
Hamilton Civic Hospitals Research Development Inc. |
Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
|
|
WO1998016559A1
(fr)
|
1996-10-15 |
1998-04-23 |
Toray Industries, Inc. |
Agent de maturation des canaux cervicaux
|
|
GB9711443D0
(en)
*
|
1997-06-03 |
1997-07-30 |
Leo Pharm Prod Ltd |
Chemical suppositions
|
|
JP3342007B2
(ja)
*
|
1997-11-20 |
2002-11-05 |
郁男 山科 |
低分子ヘパリン修飾体及び皮膚潰瘍治療剤
|
|
US6596705B1
(en)
|
1998-02-09 |
2003-07-22 |
The Regents Of The University Of California |
Inhibition of L-selectin and P-selection mediated binding using heparin
|
|
US6498246B1
(en)
|
1998-02-26 |
2002-12-24 |
Seikagaku Corporation |
Glycosaminoglycan derivatives and processes for preparing same
|
|
US6028061A
(en)
|
1998-06-18 |
2000-02-22 |
Children's Medical Center Corp |
Angiogenesis inhibitors and use thereof
|
|
EP1022289B1
(en)
*
|
1998-07-31 |
2004-07-07 |
Seikagaku Corporation |
Novel glycosaminoglycan and drug compositions containing the same
|
|
JP2002523522A
(ja)
*
|
1998-08-26 |
2002-07-30 |
ザ コラボレイティブ グループ，リミテッド． |
非誘導化水溶性ベータ−（１，３）−グルカンのレセプター
|
|
MXPA02000142A
(es)
*
|
1999-06-30 |
2003-07-21 |
Hamilton Civic Hospitals Res |
Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
|
|
JP4897991B2
(ja)
*
|
1999-07-23 |
2012-03-14 |
ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ |
超低分子量ヘパリン組成物
|
|
IT1316986B1
(it)
|
2000-01-25 |
2003-05-26 |
Sigma Tau Ind Farmaceuti |
Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
|
|
JP4585072B2
(ja)
*
|
2000-02-29 |
2010-11-24 |
扶桑薬品工業株式会社 |
ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
|
|
DK1319183T3
(da)
*
|
2000-09-12 |
2009-05-18 |
Massachusetts Inst Technology |
Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
|
|
SE521676C2
(sv)
|
2002-01-02 |
2003-11-25 |
Dilafor Ab |
Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
|
|
US20040072796A1
(en)
|
2002-04-18 |
2004-04-15 |
Embury Stephen H. |
Method and composition for preventing pain in sickle cell patients
|
|
US8071569B2
(en)
|
2002-09-20 |
2011-12-06 |
Mousa Shaker A |
Oxidized heparin fractions and their use in inhibiting angiogenesis
|
|
JP2005106694A
(ja)
*
|
2003-09-30 |
2005-04-21 |
Mochida Pharmaceut Co Ltd |
敗血症早期検出及び重篤度評価
|
|
EP1582531A1
(en)
|
2004-03-24 |
2005-10-05 |
Aventis Pharma S.A. |
Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
|
|
US20060040896A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Paringenix, Inc. |
Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
|
|
US7741311B2
(en)
|
2005-01-03 |
2010-06-22 |
Shaker Mousa |
Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
|
|
MX2008000974A
(es)
*
|
2005-07-22 |
2008-03-27 |
Univ California |
Composiciones de heparina e inhibicion de selectina.
|
|
WO2007014155A2
(en)
|
2005-07-22 |
2007-02-01 |
Trf Pharma, Inc. |
Method for treating sickle cell disease and sickle cell disease sequelae
|
|
AU2007233320B2
(en)
*
|
2006-04-04 |
2013-12-12 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
|
CN101495517B
(zh)
*
|
2006-05-25 |
2012-10-10 |
莫曼塔医药品有限公司 |
低分子量肝素及其用途
|
|
WO2009007224A1
(en)
|
2007-07-10 |
2009-01-15 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Low molecular weight heparin derivatives having neuroprotective activity
|
|
EP2205642B1
(en)
|
2007-11-02 |
2016-01-27 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
|
US8592393B2
(en)
*
|
2007-11-02 |
2013-11-26 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
US8569262B2
(en)
|
2007-11-02 |
2013-10-29 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
WO2009059283A1
(en)
*
|
2007-11-02 |
2009-05-07 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
|
US8445436B2
(en)
|
2007-12-03 |
2013-05-21 |
Florida State University Research Foundation, Inc. |
Oxytocin and melatonin compositions and associated methods for inducing labor
|
|
CN102177180A
(zh)
|
2008-04-04 |
2011-09-07 |
犹他州大学研究基金会 |
烷基化半合成的糖胺聚糖醚及其制备和使用方法
|
|
WO2010111570A1
(en)
*
|
2009-03-27 |
2010-09-30 |
E. I. Du Pont De Nemours And Company |
Polyglycerol aldehydes
|
|
EP2419736B1
(en)
|
2009-04-16 |
2014-01-29 |
Momenta Pharmaceuticals, Inc. |
Methods of assessing activity of a polysaccharide composition
|
|
US20120108538A1
(en)
|
2009-06-30 |
2012-05-03 |
James Beeson |
Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
|
|
CA2769258A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Bayer Healthcare Llc |
Modified factor ix polypeptides and uses thereof
|
|
BR112012015029A2
(pt)
*
|
2009-12-22 |
2017-06-27 |
Lifebond Ltd |
matriz reticulada, método para controlar a formação de uma matriz, método ou matriz, método para vedar um tecido contra vazamento de um fluído corporal, agente hemostático ou vedante cirúrgico, composição para vedar um ferimento, uso da composição, composição para um veículo para entrega localizada de fármaco, composição para engenharia de tecido, e método para modificar uma composição
|
|
WO2013095215A1
(en)
|
2011-12-19 |
2013-06-27 |
Dilaforette Ab |
Low anticoagulant heparins
|
|
CN104244957B
(zh)
|
2012-03-26 |
2017-11-17 |
迪乐方有限责任公司 |
用于治疗分娩停止的方法
|
|
EP2830635A4
(en)
|
2012-03-26 |
2016-03-16 |
Dilafor Ab |
COMBINATION TREATMENT OF ILLUSTRATED SULFATED GLYCOSAMINOGLYCANES
|